BALDANTI, FAUSTO
 Distribuzione geografica
Continente #
NA - Nord America 14.142
AS - Asia 10.797
EU - Europa 7.593
SA - Sud America 1.746
AF - Africa 510
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 7
Totale 34.823
Nazione #
US - Stati Uniti d'America 13.719
CN - Cina 4.029
SG - Singapore 2.780
IE - Irlanda 1.558
HK - Hong Kong 1.425
BR - Brasile 1.301
RU - Federazione Russa 1.151
VN - Vietnam 1.130
IT - Italia 987
DE - Germania 897
FI - Finlandia 651
FR - Francia 569
GB - Regno Unito 484
UA - Ucraina 427
IN - India 344
SE - Svezia 292
ZA - Sudafrica 282
CA - Canada 201
BD - Bangladesh 186
AR - Argentina 156
MX - Messico 143
JP - Giappone 140
IQ - Iraq 117
TR - Turchia 102
PL - Polonia 97
NL - Olanda 93
ES - Italia 87
EC - Ecuador 66
ID - Indonesia 66
PK - Pakistan 60
AT - Austria 57
PH - Filippine 55
VE - Venezuela 55
CO - Colombia 53
MA - Marocco 52
BE - Belgio 48
SA - Arabia Saudita 40
CL - Cile 39
UZ - Uzbekistan 34
CZ - Repubblica Ceca 26
KE - Kenya 26
AU - Australia 25
PY - Paraguay 25
LT - Lituania 24
AE - Emirati Arabi Uniti 23
CH - Svizzera 23
IL - Israele 23
RO - Romania 23
AZ - Azerbaigian 22
ET - Etiopia 22
IR - Iran 22
MY - Malesia 22
EG - Egitto 21
JO - Giordania 20
JM - Giamaica 19
PE - Perù 19
TN - Tunisia 19
DZ - Algeria 18
KR - Corea 18
KZ - Kazakistan 15
NP - Nepal 15
GR - Grecia 14
MU - Mauritius 14
SN - Senegal 13
BO - Bolivia 12
UY - Uruguay 12
CR - Costa Rica 11
SY - Repubblica araba siriana 11
AL - Albania 10
OM - Oman 10
PA - Panama 10
KG - Kirghizistan 9
LV - Lettonia 9
TH - Thailandia 9
HR - Croazia 8
TT - Trinidad e Tobago 8
BY - Bielorussia 7
DO - Repubblica Dominicana 7
GE - Georgia 7
AM - Armenia 6
AO - Angola 6
BH - Bahrain 6
HN - Honduras 6
LB - Libano 6
LK - Sri Lanka 6
RS - Serbia 6
LA - Repubblica Popolare Democratica del Laos 5
NG - Nigeria 5
PS - Palestinian Territory 5
PT - Portogallo 5
QA - Qatar 5
SR - Suriname 5
TW - Taiwan 5
DK - Danimarca 4
EE - Estonia 4
EU - Europa 4
GT - Guatemala 4
HU - Ungheria 4
LU - Lussemburgo 4
MD - Moldavia 4
Totale 34.729
Città #
San Jose 1.916
Dublin 1.535
Singapore 1.470
Ashburn 1.459
Hong Kong 1.395
Chandler 1.314
Dallas 1.219
Beijing 802
Jacksonville 576
Boardman 523
Nanjing 505
Council Bluffs 429
New York 420
Los Angeles 401
Ho Chi Minh City 375
Lauterbourg 374
Munich 347
Helsinki 327
Princeton 288
Wilmington 281
Hanoi 276
Lawrence 257
Shanghai 257
Johannesburg 242
Nanchang 232
Moscow 216
Redondo Beach 192
Medford 188
Hebei 183
Milan 182
Shenyang 173
Changsha 165
Pavia 143
Jiaxing 142
Turku 133
São Paulo 129
Tokyo 126
Buffalo 125
Ann Arbor 123
Hangzhou 111
Orem 109
Santa Clara 105
Tianjin 102
Seattle 101
Frankfurt am Main 87
Houston 87
The Dalles 86
Brooklyn 83
Chennai 83
Woodbridge 82
Warsaw 80
Toronto 76
Da Nang 62
Nuremberg 62
London 60
Mexico City 58
Montreal 58
Rome 58
Denver 57
Fairfield 56
Poplar 56
Atlanta 52
Baghdad 52
Columbus 52
San Francisco 52
Washington 51
Chicago 50
Phoenix 49
Pune 49
Falkenstein 48
Boston 44
Brussels 42
Haiphong 41
Norwalk 41
Rio de Janeiro 39
Düsseldorf 37
Stockholm 36
Ankara 35
Guangzhou 34
Mumbai 34
Tashkent 33
Amsterdam 31
Biên Hòa 31
Belo Horizonte 30
Zhengzhou 30
Paris 28
Quito 28
Jinan 27
Falls Church 26
Piscataway 25
Manchester 24
Nairobi 23
Porto Alegre 23
Addis Ababa 21
Dhaka 21
Istanbul 21
Lahore 21
Santiago 21
Vienna 21
Baku 20
Totale 22.502
Nome #
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 173
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 157
Accumulation of defective HIV-1 variants in a patient with slow disease progression. 153
Adoptive transfer of herpesvirus-specific cytotoxic T lymphocytes in transplant recipients 151
Compartmentalized replication of sars-cov-2 in upper vs. Lower respiratory tract assessed by whole genome quasispecies analysis 150
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 150
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 149
Detection of haemagglutinin D222 polymorphisms in influenza A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing. 142
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 141
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 139
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 139
Acute cytomegalovirus infection as a cause of venous thromboembolism. 138
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 138
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 137
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 134
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 133
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs 132
A new Real-Time RT-PCR Assay for Detection of Human Enterovirus 68 (EV-D68) in Respiratory Samples. 130
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 130
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 129
Torque teno virus and cancers: current knowledge 127
Herpes virus-6 chromosomal integration misled the management of Crohn’s disease 127
Contribution of Enteroviruses to Acute Central Nervous System or Systemic Infections in Northern Italy (2015-2017): Is It Time to Establish a National Laboratory-Based Surveillance System? 127
Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study 127
T-lymphocytes with high proliferative capacity correlate with control of viral suppression in chronically untreated HIV-1 infected individual 126
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey 126
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 125
19n01, a Broadly Neutralizing Antibody Against Omicron BA.1, BA.2, BA.4/5, and Other SARS-CoV-2 Variants of Concern 124
Concomitant Resistance to Cefiderocol and Ceftazidime/Avibactam in Two Carbapenemase-Producing Klebsiella pneumoniae Isolates from Two Lung Transplant Patients 124
A novel human enterovirus C (EV-C118) identified in two children hospitalised because of acute otitis media and community-acquired pneumonia in Israel. 124
Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease 124
Zika virus isolation from semen 123
The pentameric complex of human cytomegalovirus: Cell tropism, virus dissemination, immune response and vaccine development 123
Systematic analysis of human oncogenic viruses in colon cancer revealed EBV latency in lymphoid infiltrates. 123
Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: Need for mucosal viral load measurement. 122
Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy. 122
Usutu Virus Antibodies in Blood Donors and Healthy Forestry Workers in the Lombardy Region, Northern Italy 122
Diagnosis and counseling of fetal and neonatal HCMV infection. 120
Reconstructing the recent West Nile virus lineage 2 epidemic in Europe and Italy using discrete and continuous phylogeography 120
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia. 120
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 119
12 weeks ombitasvir/paritaprevir–ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 119
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 118
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation 118
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. 118
Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic 118
Viral outbreaks in neonatal intensive care units: what we do not know. 117
Postinfectious neurologic syndromes: A prospective cohort study 117
Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial 117
Baseline amino acid substitutions in the NS5A ISDR and PKR binding domain of hepatitis C and different fibrosis levels and levels of development of hepatocellular carcinoma in patients treated with DAAs 117
Guillain-Barré syndrome associated with SARS-CoV-2 117
Enterovirus-D68 (EV-D68) in pediatric patients with respiratory infection: The circulation of a new B3 clade in Italy 116
Expanding usutu virus circulation in italy: Detection in the Lazio region, central Italy, 2017 to 2018 115
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 115
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice 114
Human enterovirus and parechovirus infections in newborns with sepsis-like illness and neurological disorders. 113
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 113
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers 113
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 113
Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy 113
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 112
Persistent human cosavirus infection in lung transplant recipient, Italy. 111
A case of leprosy in a nonendemic country 111
Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linted immunospot assay. 110
Epstein-Barr Virus positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma. 110
Authors’ reply: Two severe human cases due to swine influenza a (H1N1)v in October 2016 in Europe were chronologic coincident yet distinct events 110
Occult HIV infection in a large sample of health-care users in Lombardy, Italy in 2014-2015: Implications for control strategies 110
Impact of immunosuppressive treatment on the immunogenicity of mRNA Covid-19 vaccine in vulnerable patients with giant cell arteritis 110
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 109
Imported hantavirus cardiopulmonary syndrome in an Italian traveller returning from Cuba. 109
Comparison of three different methods for the evaluation of IL28 and ITPA polymorphisms in patients infected with HCV. 109
Comparison of immunologic and molecular assays for the diagnosis of gastrointestinal viral infections. 109
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 109
FilmArray GI panel performance for the diagnosis of acute gastroenteritis or hemorragic diarrhea 108
Cellular DNA quantification in respiratory samples for the normalization of viral load: a real need? 108
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 107
Emerging and re-emerging virus infections in neonates and young pediatric patients. 107
Acute respiratory distress syndrome in adenovirus type 4 pneumonia: A case report 107
Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease. 107
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol 107
Complete genome characterization of enterovirus 104 circulating in Northern Italy shows recombinant origin of the P3 region. 107
Characterization of varicella-zoster (Vzv) specific t cell response in healthy subjects and transplanted patients by using enzyme linked immunospot (elispot) assays 107
Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects 106
A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology 106
Monitoring of human cytomegalovirus DNAemia during primary infection in transmitter and non-transmitter mothers 106
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies 106
High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders 106
Enterobacter asburiae ST229: an emerging carbapenemases producer 105
Lung ultrasound presentation of COVID-19 patients: phenotypes and correlations 105
Human Cytomegalovirus-Specific Memory CD4+T-Cell Response and Its Correlation with Virus Transmission to the Fetus in Pregnant Women with Primary Infection 105
Genome characterisation of enteroviruses 117 and 118: a new group within human enterovirus species C. 105
Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation 104
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 104
Chikungunya infection in a human immunodeficiency virus-infected kidney transplant recipient returning to Italy from the Dominican Republic 104
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. 104
Detection of SARS-CoV-2 in Cancellous Bone of Patients with COVID-19 Disease Undergoing Orthopedic Surgery: Laboratory Findings and Clinical Applications 103
A versatile method for multiclass determination of β-lactam drugs in urine by solid-phase extraction followed by HILIC-UV 103
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 103
Dengue Virus-Specific Humoral and T Cellular Immune Response in Italian Residents and Travelers Returning from Endemic Areas 103
Comparative analysis of SARS-CoV-2 quasispecies in the upper and lower respiratory tract shows an ongoing evolution in the spike cleavage site 102
Totale 11.915
Categoria #
all - tutte 161.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 161.944


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 0 0 0 0 0 0 40
2021/20221.251 23 14 27 46 52 29 33 65 72 42 179 669
2022/20234.066 405 278 77 280 328 348 6 203 1.820 41 205 75
2023/20242.446 278 396 101 128 252 594 184 159 29 100 106 119
2024/20256.630 163 452 141 215 112 391 372 382 1.658 365 727 1.652
2025/202616.312 1.189 1.051 1.881 1.796 1.870 638 2.983 811 1.557 1.277 882 377
Totale 35.488